Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial

Adjuvant endocrine hormonal therapy (EHT) is highly effective and appropriate for nearly all breast cancer patients with hormone receptor-positive tumors, which represent 75% of all breast cancer diagnoses. Long-term use of EHT reduces recurrence rates and nearly halves the risk of death during the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalela, P., Munoz, E., Inupakutika, D., Kaghyan, S., Akopian, D., Kaklamani, V., Lathrop, K., Ramirez, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202663/
https://www.ncbi.nlm.nih.gov/pubmed/30377674
http://dx.doi.org/10.1016/j.conctc.2018.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202663/
https://www.ncbi.nlm.nih.gov/pubmed/30377674
http://dx.doi.org/10.1016/j.conctc.2018.10.001

Ejemplares similares